Dishman Carbogen Amcis Share Price Target For Tomorrow, Next Week & Next Month
Dishman Carbogen Amcis Limited | |||
 | Price: ₹253.70 (-0.55%) | ||
| 52 Week Low: ₹155.05 52 Week High: ₹307.98 | |||
| Market Capital: 3,567.36 Crore (Smallcap) | |||
| Healthcare -> Biotechnology | |||
Dishman Carbogen Amcis Stock Comparison: Dishman Carbogen Amcis vs Supriya Lifescience | Dishman Carbogen Amcis vs TIL | Dishman Carbogen Amcis vs Zota Health Care | Dishman Carbogen Amcis vs Yatharth Hospital & Trauma Care Services Limited | Dishman Carbogen Amcis vs INDRAMEDCO | Dishman Carbogen Amcis vs Thyrocare Technologies | |||
Show Table of Contents
Dishman Carbogen Amcis Recent Performance
Over the past 406 trading days, the value of Dishman Carbogen Amcis's stock has gained ₹100.90 (+66.03%). On 07 Nov 2023, one share was worth ₹152.80 and by 02 Jul 2025, the value jumped to ₹253.70. During this period it created a highest high of ₹307.98 and lowest low of ₹133.00.
Dishman Carbogen Amcis Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 277.5 (+9.38%) | Price Action: May 2025 High |
| Tomorrow Target 2 | 274.5 (+8.19%) | Price Action: 03 Jun 2025 High |
| Tomorrow Target 1 | 271 (+6.81%) | Price Action: 29 May 2025 High |
| Current Price | 253.70 | Dishman Carbogen Amcis's share price as of 02 Jul 2025 |
| Stop Loss 1 | 238 (-6.19%) | Price Action: Jun 2025 Low |
| Stop Loss 2 | 235 (-7.38%) | Price Action: Apr 2025 High |
| Stop Loss 3 | 231.49 (-8.76%) | Price Action: 03 Feb 2025 High |
Summary
02 Jul 2025: Dishman Carbogen Amcis finished the day at ₹253.70, losing ₹-1.40 (-0.55%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -8.75% to 9.38% with:
- Target prices: ₹271 to ₹277.5
- Support levels: ₹238 to ₹231.49
- Recent high: ₹258.00
- Recent low: ₹250.00
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Dishman Carbogen Amcis Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 263.35 (+3.8%) | Price Action: 02 Jun 2025 Low |
| Next Week Target 2 | 260.6 (+2.71%) | Price Action: 17 Jun 2025 Low |
| Next Week Target 1 | 257.64 (+1.55%) | Fibonacci Extension Level 23.60% |
| Current Price | 253.70 | Dishman Carbogen Amcis's share price as of 02 Jul 2025 |
| Stop Loss 1 | 252.32 (-0.55%) | Fibonacci Retracement Level 38.20% |
| Stop Loss 2 | 249.64 (-1.61%) | Price Action: Nov 2024 High |
| Stop Loss 3 | 246.8 (-2.72%) | Price Action: 20 Jun 2025 High |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -2.72% to 3.80% with:
- Upper targets: ₹257.64 to ₹263.35
- Support levels: ₹252.32 to ₹246.8
Dishman Carbogen Amcis Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 281 (+10.76%) | Price Action: 13 Jun 2025 High |
| Next Month Target 2 | 278.15 (+9.63%) | Price Action: 12 Jun 2025 Low |
| Next Month Target 1 | 275.35 (+8.52%) | Price Action: 26 May 2025 High |
| Current Price | 253.70 | Dishman Carbogen Amcis's share price as of 02 Jul 2025 |
| Stop Loss 1 | 247.6 (-2.41%) | Price Action: 18 Jun 2025 Low |
| Stop Loss 2 | 244.8 (-3.51%) | Price Action: May 2024 High |
| Stop Loss 3 | 242 (-4.62%) | Price Action: 24 Jun 2025 Low |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -4.61% to 10.76% with:
- Target range: ₹275.35 to ₹281
- Support levels: ₹247.6 to ₹242
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
